COL1A1 and breast cancer: We go on to show that CS-E negatively regulates Wnt/beta-catenin signaling, a known pro-tumorigenic pathway, and that Col1a1 is a positively regulated target gene of the Wnt/beta-catenin pathway in breast cancer cells.